Premium
Life Sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund) has exited Sutures India Private Limited with cash on cash returns of 3.2x on its three-year-old investment, according to a top official. EILSF sold its stake to CX Partners, which recently concluded a transaction to invest $37 million the Bangalore-based ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
